Kainic acid-induced microglial activation is attenuated in aged interleukin-18 deficient mice

J Neuroinflammation. 2010 Apr 14:7:26. doi: 10.1186/1742-2094-7-26.

Abstract

Background: Previously, we found that interleukin (IL)-18 deficiency aggravates kainic acid (KA)-induced hippocampal neurodegeneration in young C57BL/6 mice due to an over-compensation by IL-12. Additionally, IL-18 participates in fundamental inflammatory processes that increase during aging. In the present study, we were interested in the role of IL-18 in KA-induced neurodegeneration in aged female C57BL/6 mice.

Methods: Fifteen aged female IL-18 knockout (KO) and 15 age-matched wild-type (WT) mice (18 to 19 months old) were treated with KA at a dose of 25 mg/kg body weight intranasally. Seizure activities and behavioral changes were rated using a 6-point scoring system and open-field test, respectively. Seven days after KA treatment, degenerating neurons were detected by Nissl's method and Fluoro-Jade B staining; and microglial activation was analyzed by immunohistochemistry and flow cytometry.

Results: Aged female IL-18 KO and WT mice showed similar responses to treatment with KA as demonstrated by comparable seizure activities, behavioral changes and neuronal cell death. However, aged female IL-18 KO mice failed to exhibit the strong microglial activation shown in WT mice. Interestingly, even though the number of activated microglia was less in KA-treated IL-18 KO mice than in KA-treated WT mice, the proportion of microglia that expressed the cytokines tumor necrosis factor (TNF)-alpha, IL-6 and IL-10 was higher in KA-treated IL-18 KO mice.

Conclusion: Deficiency of IL-18 attenuates microglial activation after KA-induced excitotoxicity in aged brain, while the net effects of IL-18 deficiency are balanced by the enhancement of other cytokines, such as TNF-alpha, IL-6 and IL-10.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology*
  • Animals
  • Brain / pathology
  • Excitatory Amino Acid Agonists / pharmacology*
  • Female
  • Flow Cytometry
  • Immunohistochemistry
  • Interleukin-10 / biosynthesis
  • Interleukin-18 / genetics*
  • Interleukin-18 / physiology*
  • Interleukin-6 / biosynthesis
  • Kainic Acid / pharmacology*
  • Macrophage Activation / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia / drug effects*
  • Motor Activity / physiology
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / pathology
  • Seizures / pathology
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Excitatory Amino Acid Agonists
  • Interleukin-18
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Kainic Acid